Wei‐En Yang
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circadian rhythm and melatonin
Papers in
-
- RNA modifications and cancer 3
- Cell death mechanisms and regulation 3
-
- Protease and Inhibitor Mechanisms 8
- Cancer-related molecular mechanisms research 3
- Co-authors
- Shun‐Fa Yang (28 shared papers)Chiao‐Wen Lin (22 shared papers)Shih‐Chi Su (4 shared papers)Ming‐Ju Hsieh (7 shared papers)Wen‐Hung Chung (2 shared papers)Mu‐Kuan Chen (10 shared papers)Rüssel J. Reiter (1 shared paper)Chun‐Wen Su (10 shared papers)
- Journals
- International Journal of Medical Sciences (3 papers)Expert Opinion on Therapeutic Targets (2 papers)International Journal of Molecular Sciences (2 papers)Environmental Toxicology (2 papers)Oncotarget (2 papers)
- Partner nations
- TaiwanUnited StatesSingapore
In The Last Decade
Wei‐En Yang
32 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 391
- Endocrine and Autonomic Systems 166
- Applied Microbiology and Biotechnology 31
- Molecular Medicine 52
- Complementary and alternative medicine 86
Countries citing papers authored by Wei‐En Yang
This map shows the geographic impact of Wei‐En Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐En Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐En Yang more than expected).
Fields of papers citing papers by Wei‐En Yang
This network shows the impact of papers produced by Wei‐En Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐En Yang. The network helps show where Wei‐En Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐En Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 253 | |
| 2 | 2015 | 125 | |
| 3 | 2017 | 111 | |
| 4 | 2013 | 111 | |
| 5 | 2007 | 90 | |
| 6 | 2016 | 77 | |
| 7 | 2019 | 75 | |
| 8 | 2017 | 52 | |
| 9 | 2016 | 52 | |
| 10 | 2014 | 45 | |
| 11 | 2014 | 33 | |
| 12 | 2017 | 31 | |
| 13 | 2019 | 28 | |
| 14 | 2019 | 27 | |
| 15 | 2018 | 26 | |
| 16 | 2021 | 19 | |
| 17 | 2021 | 15 | |
| 18 | 2024 | 14 | |
| 19 | 2017 | 13 | |
| 20 | 2012 | 13 |
About Wei‐En Yang
Wei‐En Yang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pharmacology, having authored 32 papers that have together received 1.3k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (8 papers), Peptidase Inhibition and Analysis (5 papers), RNA modifications and cancer (3 papers), Cell death mechanisms and regulation (3 papers), Inflammation biomarkers and pathways (3 papers), Cancer-related molecular mechanisms research (3 papers), Natural Compounds in Disease Treatment (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Cancer Research (391 citations), Endocrine and Autonomic Systems (166 citations), Applied Microbiology and Biotechnology (31 citations), Molecular Medicine (52 citations) and Complementary and alternative medicine (86 citations). Wei‐En Yang has collaborated with scholars based in Taiwan, United States and Singapore. Frequent co-authors include Shun‐Fa Yang, Chiao‐Wen Lin, Shih‐Chi Su, Ming‐Ju Hsieh, Wen‐Hung Chung, Mu‐Kuan Chen, Rüssel J. Reiter, Chun‐Wen Su, Pei‐Ni Chen and Shih‐Chi Su. Their work appears in journals such as International Journal of Medical Sciences, Expert Opinion on Therapeutic Targets, International Journal of Molecular Sciences, Environmental Toxicology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.